Common Sense Oncology shared on LinkedIn:
“Cancer trials increasingly measure quality of life. But are we asking-and answering-the questions patients really need answered?
- What are the chances a treatment will make me feel better or worse?
- How will it affect my ability to function?
- How long might those effects last?
- And how do we weigh quality of life against the potential benefits of treatment?
Join Drs. Madeline Pe, Ian Tannock, and Michael Brundage on November 13 at 11 a.m. ET for a high-level conversation about making quality-of-life evidence more meaningful for patients, followed by an extended panel discussion and Q&A.
You can also read:
Exercise as Part of Cancer Care: Lessons From the CHALLENGE Trial – Common Sense Oncology